基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research summary
My research group is interested in altering both the specificity and the function of gene-modified immune cells. These immune cells can then be used to treat cancer, infection or immune system disorders.
My research team investigates basic cellular and molecular mechanisms that influence how immune cells behave and how they recognise that cancer cells are different to normal cells, or why, in some cases, this does not occur. We are exploring ways to alter the genetic programming of these cells to improve their function and enhance their ability to kill cancer cells.
We also run a number of phase I ('first in human') clinical trials exploring the safety of these treatments in adult patients, where other treatments may have failed. These new approaches to cell therapy can be used in isolation or together with a stem cell (bone marrow) transplant procedure. We are particularly interested in TCR gene-modified T cells and genetically engineered stem cells.
I trained in Clinical Medicine at the University of Cambridge before specialising in Haemato-oncology and allogeneic bone marrow transplantation. I am currently a Transplant Consultant at University College London Hospital NHS FT and the Royal Free London NHS FT. In receive research funding from the Bloodwise, MRC, CRUK Experimental Cancer Medicine Centre and the Wellcome Trust.
I am director of the NIHR UCLH/UCL Biomedical Research Centre Inflammation, Immunity and Immunotherapeutics research programme and Co-Chair of the UCL Cell, Gene and Regenerative Medicine Therapeutic Innovation Network.
My research group is interested in altering both the specificity and the function of gene-modified immune cells. These immune cells can then be used to treat cancer, infection or immune system disorders.
My research team investigates basic cellular and molecular mechanisms that influence how immune cells behave and how they recognise that cancer cells are different to normal cells, or why, in some cases, this does not occur. We are exploring ways to alter the genetic programming of these cells to improve their function and enhance their ability to kill cancer cells.
We also run a number of phase I ('first in human') clinical trials exploring the safety of these treatments in adult patients, where other treatments may have failed. These new approaches to cell therapy can be used in isolation or together with a stem cell (bone marrow) transplant procedure. We are particularly interested in TCR gene-modified T cells and genetically engineered stem cells.
I trained in Clinical Medicine at the University of Cambridge before specialising in Haemato-oncology and allogeneic bone marrow transplantation. I am currently a Transplant Consultant at University College London Hospital NHS FT and the Royal Free London NHS FT. In receive research funding from the Bloodwise, MRC, CRUK Experimental Cancer Medicine Centre and the Wellcome Trust.
I am director of the NIHR UCLH/UCL Biomedical Research Centre Inflammation, Immunity and Immunotherapeutics research programme and Co-Chair of the UCL Cell, Gene and Regenerative Medicine Therapeutic Innovation Network.
Research Interests
Papers共 275 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sameer Bahal,Marta Zinicola, Shefta E. Moula,Thomas E. Whittaker,Andrea Schejtman,Asma Naseem,Elena Blanco,Winston Vetharoy,Yi-Ting Hu, Rajeev Rai,Eduardo Gomez-Castaneda, Catarina Cunha Santos,
Journal of Allergy and Clinical Immunologyno. 1 (2024): 195-208.e8
Ariharan Anantharachagan, Sook Yin Loh,Siobhan O. Burns,Arian Laurence,Susan Tadros,Eleni Tholouli, Yadanar Lwin, Nicolas Martinez-Calle, P. Vaitla,Emma C. Morris
Journal of Allergy and Clinical Immunology: Globalno. 1 (2024): 100191-100191
Frontiers in immunology (2024): 1386132-1386132
Zainab M. Golwala, Nikita Gireesh Bhat,Jinhua Xu-Bayford, Tanja Stankova,Stuart Adams,Emma C. Morris,Waseem Qasim,Claire Booth,Austen Worth,Maaike A. Kusters,Reem Elfeky
Catharina Schuetz, Julia Gerke,Markus Johannes Ege, Jolan Eszter Walter,Maaike Kusters,Austen J.J. Worth,Jennifer A Kanakry,Dimana Dimitrova,Beata Wolska-Kusnierz,Karin Chen,Ekrem Unal,Musa Karakukcu,
Proceedings of the National Academy of Sciencesno. 21 (2023): e2301330120-e2301330120
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn